Novel mechanism-based treatments for pediatric anxiety and depressive disorders

被引:2
|
作者
Sylvester, Chad M. [1 ,2 ]
Luby, Joan L. [1 ]
Pine, Daniel S. [3 ]
机构
[1] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA
[2] Washington Univ, Dept Radiol, St Louis, MO 63110 USA
[3] NIMH, Emot & Dev Branch, St Louis, MO USA
关键词
ATTENTION BIAS MODIFICATION; COGNITIVE-BEHAVIORAL THERAPY; TRANSCRANIAL MAGNETIC STIMULATION; INTRINSIC FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX ACTIVATION; CLINICAL-PRACTICE GUIDELINE; CHILD INTERACTION THERAPY; DSM-IV DISORDERS; COMPARATIVE EFFICACY; ADOLESCENT ANXIETY;
D O I
10.1038/s41386-023-01709-x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pediatric anxiety and depressive disorders are common, can be highly impairing, and can persist despite the best available treatments. Here, we review research into novel treatments for childhood anxiety and depressive disorders designed to target underlying cognitive, emotional, and neural circuit mechanisms. We highlight three novel treatments lying along a continuum relating to clinical impact of the disorder and the intensity of clinical management required. We review cognitive training, which involves the lowest risk and may be applicable for problems with mild to moderate impact; psychotherapy, which includes a higher level of clinical involvement and may be sufficient for problems with moderate impact; and brain stimulation, which has the highest potential risks and is therefore most appropriate for problems with high impact. For each treatment, we review the specific underlying cognitive, emotional, and brain circuit mechanisms that are being targeted, whether treatments modify those underlying mechanisms, and efficacy in reducing symptoms. We conclude by highlighting future directions, including the importance of work that leverages developmental windows of high brain plasticity to time interventions to the specific epochs in childhood that have the largest and most enduring life-long impact.
引用
收藏
页码:262 / 275
页数:14
相关论文
共 50 条
  • [21] Novel, mechanism-based therapies for cystic fibrosis
    Rubenstein, RC
    CURRENT OPINION IN PEDIATRICS, 2005, 17 (03) : 385 - 392
  • [22] Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations
    Sonmez, A. Irem
    Almorsy, Ammar
    Ramsey, Laura B.
    Strawn, Jeffrey R.
    Croarkin, Paul E.
    DEPRESSION AND ANXIETY, 2020, 37 (08) : 747 - 759
  • [23] The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders
    Pine, DS
    Cohen, P
    Gurley, D
    Brook, J
    Ma, YJ
    ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (01) : 56 - 64
  • [24] Clinical efficacy of SSRI for anxiety and depressive disorders and its mechanism of action
    Inoue, T
    Koyama, T
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 26P - 26P
  • [25] ANXIETY IN DEPRESSIVE-DISORDERS
    KUHS, H
    COMPREHENSIVE PSYCHIATRY, 1991, 32 (03) : 217 - 228
  • [26] Alcohol, anxiety, and depressive disorders
    Schuckit, MA
    ALCOHOL HEALTH & RESEARCH WORLD, 1996, 20 (02): : 81 - 85
  • [27] BRIEF SCREENING TOOLS FOR PEDIATRIC PATIENTS WITH DEPRESSIVE OR ANXIETY DISORDERS: A SCOPING REVIEW
    Song, Kaiwen
    Lorber, Sharon
    Mian, Irfan
    Leslie, Karen
    Crosbie, Jennifer
    Munns, Catherine
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2018, 57 (10): : S186 - S186
  • [28] Paraprofessionals for anxiety and depressive disorders
    den Boer, PCAM
    Wiersma, D
    Russo, S
    van den Bosch, RJ
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02):
  • [29] The burden of anxiety and depressive disorders
    Andrews, G
    CURRENT OPINION IN PSYCHIATRY, 1998, 11 (02) : 121 - 123
  • [30] THE IMPACT OF FUNDING SOURCE ON ANTIDEPRESSANT TRIAL OUTCOMES IN PEDIATRIC DEPRESSIVE AND ANXIETY DISORDERS
    Mills, Jeffrey A.
    Mossman, Sarah
    Strawn, Jeffrey Robert
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S253 - S253